These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 12190323
1. Synthesis of a small library of 3-(carboranylalkyl)thymidines and their biological evaluation as substrates for human thymidine kinases 1 and 2. Al-Madhoun AS, Johnsamuel J, Yan J, Ji W, Wang J, Zhuo JC, Lunato AJ, Woollard JE, Hawk AE, Cosquer GY, Blue TE, Eriksson S, Tjarks W. J Med Chem; 2002 Aug 29; 45(18):4018-28. PubMed ID: 12190323 [Abstract] [Full Text] [Related]
2. Synthesis of 5-(carboranylalkylmercapto)-2'-deoxyuridines and 3-(carboranylalkyl)thymidines and their evaluation as substrates for human thymidine kinases 1 and 2. Lunato AJ, Wang J, Woollard JE, Anisuzzaman AK, Ji W, Rong FG, Ikeda S, Soloway AH, Eriksson S, Ives DH, Blue TE, Tjarks W. J Med Chem; 1999 Aug 26; 42(17):3378-89. PubMed ID: 10464024 [Abstract] [Full Text] [Related]
3. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy. Byun Y, Yan J, Al-Madhoun AS, Johnsamuel J, Yang W, Barth RF, Eriksson S, Tjarks W. J Med Chem; 2005 Feb 24; 48(4):1188-98. PubMed ID: 15715485 [Abstract] [Full Text] [Related]
7. Synthesis of N3-substituted carboranyl thymidine bioconjugates and their evaluation as substrates of recombinant human thymidine kinase 1. Agarwal HK, McElroy CA, Sjuvarsson E, Eriksson S, Darby MV, Tjarks W. Eur J Med Chem; 2013 Feb 24; 60():456-68. PubMed ID: 23318906 [Abstract] [Full Text] [Related]
8. Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy. Al-Madhoun AS, Johnsamuel J, Barth RF, Tjarks W, Eriksson S. Cancer Res; 2004 Sep 01; 64(17):6280-6. PubMed ID: 15342416 [Abstract] [Full Text] [Related]
9. Synthesis of N3-substituted thymidine analogues for measurement of cellular kinase activity. Ghosh P, Pal A, Shavrin A, Bornmann W, Gelovani JG, Alauddi MM. Med Chem; 2008 Sep 01; 4(5):503-12. PubMed ID: 18782048 [Abstract] [Full Text] [Related]
10. Preparation and biological evaluation of 10B-enriched 3-[5-{2-(2,3-dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH), a new boron delivery agent for boron neutron capture therapy of brain tumors. Byun Y, Thirumamagal BT, Yang W, Eriksson S, Barth RF, Tjarks W. J Med Chem; 2006 Sep 07; 49(18):5513-23. PubMed ID: 16942024 [Abstract] [Full Text] [Related]
18. Comparative molecular field analysis and comparative molecular similarity indices analysis of boron-containing human thymidine kinase 1 substrates. Bandyopadhyaya AK, Tiwari R, Tjarks W. Bioorg Med Chem; 2006 Oct 15; 14(20):6924-32. PubMed ID: 16828556 [Abstract] [Full Text] [Related]
19. 3'-[4-Aryl-(1,2,3-triazol-1-yl)]-3'-deoxythymidine analogues as potent and selective inhibitors of human mitochondrial thymidine kinase. Van Poecke S, Negri A, Gago F, Van Daele I, Solaroli N, Karlsson A, Balzarini J, Van Calenbergh S. J Med Chem; 2010 Apr 08; 53(7):2902-12. PubMed ID: 20218622 [Abstract] [Full Text] [Related]
20. Hydrophilically enhanced 3-carboranyl thymidine analogues (3CTAs) for boron neutron capture therapy (BNCT) of cancer. Narayanasamy S, Thirumamagal BT, Johnsamuel J, Byun Y, Al-Madhoun AS, Usova E, Cosquer GY, Yan J, Bandyopadhyaya AK, Tiwari R, Eriksson S, Tjarks W. Bioorg Med Chem; 2006 Oct 15; 14(20):6886-99. PubMed ID: 16831554 [Abstract] [Full Text] [Related] Page: [Next] [New Search]